Low BMI Is a Predictor of Death for TAVI

Courtesy of Dr. Carlos Fava.

 

low BMI death TAVI

 

Body mass index (BMI) has always played an important role in heart surgery. However, there is little evidence on BMI effects on TAVI.

This study included 491 patients, which were divided according to BMI into:

 

  • low (<20 Kg/m2 )
  • normal (20-24.9 Kg/m2 )
  • overweight (25-30 Kg/m2 )
  • obese (>30 Kg/m2 )

 

BMI was low in 43 patients (8.7%), normal in 148 (30.1%), overweight in 162 (33%) and obese in 138 (28.1%).

Obese patients were younger, diabetes was more frequent among morbid obese, but there were fewer with prior MI.

STS score was inversely associated with BMI:

Low weight: 11.4±4.9

Normal: 9.1±4.8

Overweight: 8.4±4.3

Obesity: 7.9±4

[p<0.001]

Ejection fraction was also inversely associated to BMI, but the opposite happened with the aortic valve area.

There was no difference in procedural success, except for longer fluoroscopy time in the group with morbid obesity. Vascular complications and transfusions (VARC-2 criteria) were higher in the low BMI group, while acute kidney injury was higher in the highest BMI group.

At one year follow up, all-cause mortality was higher in the low BMI group compared to the other 3 groups (p=0.003).

In multivariable analyzis, BMI <20 Kg/mwas an independent predictor of mortality (HR=2.45; p=0.01).

 

Conclusion

Body mass index <20 Kg/mshould be considered a fragility marker during screening for TAVI of patients with severe aortic stenosis, since it is associated to high mortality, while obese patients presented similar mortality risk to those of normal weight.

 

Editorial Comment

BMI should be included as part of patient screening routine procedures when considering TAVI, because it is associated with in-hospital complications and mortality. BMI could be used as a sign of fragility. We should controlling fluid balance in morbid obesity because these patients present higher kidney failure rate after implantation, which can be associated to loss of volume, hard to recover immediately after procedure.

 

Courtesy of Dr. Carlos Fava. Favaloro Foundation, Buenos Aires, Argentina.

 

Original Title: Body Mass Index Association with Survival in Severe Aortic Stenosis Patients Undergoing Transcatheter Aortic Valve Replacement

Reference: Edward Koifman, et al. Cateheterization cardiovascular Intervention 2016;88:118-124

 

We value your opinion. You are more than welcome to leave your comments, thoughts, questions or suggestions here below.

More articles by this author

Prospective Analysis of the Feasibility of the PASCAL System for Transcatheter Mitral Repair: OneForAll Registry

Courtesy of Dr. Juan Manuel Pérez. Mitral transcatheter edge-to-edge repair (M-TEER) is an effective option for patients with severe mitral regurgitation who are at high...

Left Bundle Branch Block after TAVR: What Is Its Impact?

Courtesy of Dr. Juan Manuel Pérez. Left bundle branch block (LBBB) is a common complication following transcatheter aortic valve replacement (TAVR), which can be either...

Multicenter Experience with 3D Intracardiac Echocardiography for Guiding Interventional Cardiac Procedures

Courtesy of Dr. Juan Manuel Pérez. Imaging techniques play a fundamental role in interventional cardiac procedures. Intracardiac echocardiography (ICE) appears as an alternative to transesophageal...

Pathology of Self-Expanding Transcatheter Aortic Bioprostheses and Hypoattenuated Leaflet Thickening

Courtesy of Dr. Juan Manuel Pérez. Despite the available long term followup data on of transcatheter aortic valve replacement (TAVR), bioprosthesis durability continues under debate....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...